TARA VIETMEIER: Open Payments
NPI 1073801478 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 11 payments from 6 companies in 2025. Trend: 2023 $75 · 2024 $117 · 2025 $272
Food & beverage: $227Education: $45
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $84 |
| Gilead Sciences, Inc. | 2 | $53 |
| Paratek Pharmaceuticals, Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| ABBVIE INC. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: NUZYRA, ZERBAXA, Cresemba, Yeztugo, DALVANCE, VOWST.
Industry payments across PA — which companies pay providers there.
